Hepatitis B viral replication markers and hepatic fibrosis in untreated chronic hepatitis B viurs infection with and without HIV coinfection in Zambia.

Muula, Guy K; Bosomprah, Samuel; Sinkala, Edford; Nsokolo, Bright; Musonda, Taonga; Hamusonde, Kalongo; Bhattacharya, Debika; Lauer, Georg; Chung, Raymond T; Mulenga, Lloyd B; Wandeler, Gilles; Vinikoor, Michael J (2023). Hepatitis B viral replication markers and hepatic fibrosis in untreated chronic hepatitis B viurs infection with and without HIV coinfection in Zambia. AIDS, 37(13), pp. 2015-2020. Wolters Kluwer Health 10.1097/QAD.0000000000003659

	Text HBV_viral_replication_markers_and_hepatic_fibrosis.307.pdf - Accepted Version Restricted to registered users only until 18 July 2024. Available under License Publisher holds Copyright. Download (756kB) | Request a copy
	Text Muula_AIDS_2023.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (671kB) | Request a copy

BACKGROUND

To inform novel therapies, a more nuanced understanding of HIV's impact on hepatitis B virus (HBV) natural history is needed, particularly in high burden countries.

METHODS

In Lusaka, Zambia, we compared prospectively-recruited adults (18+ years) with chronic HBV infection, with and without HIV, pre-therapy. We excluded those with treatment-experience or HBV diagnosis due to clinical suspicion. We assessed HBV DNA levels, hepatitis B e antigen, CD4 (if coinfection), and liver disease (transient elastography [TE], serum alanine aminotransferase). In multivariable analyses, we evaluated the association of HIV overall and by level of CD4 count on these markers.

RESULTS

Among 713 adults analyzed, median age was 33 years, 63.0% were male, and 433 had HBV/HIV coinfection. Median CD4 count was 200 cells/mm3. HBV DNA was >2,000 IU/ml for 311 (51.0%) and 227 (32.5%) were HBeAg-positive. 15.5% had advanced fibrosis or cirrhosis. HIV coinfection was associated with 5-fold increased HBV DNA levels (adjusted geometric mean ratio, 5.78; 95% confidence interval, 2.29-14.62) and 2 times the odds of HBeAg-positivity (adjusted odds ratio, 2.54; 95% CI, 1.59-4.08). These associations were significant only at CD4 counts 100-350 and <100 cells/mm3. HIV was not associated with markers of fibrosis or ALT.

DISCUSSION

HIV's impact on HBV natural history likely depends on the degree and duration of immune suppression. There is strong rationale to monitor HBV DNA in people with HBV/HIV coinfection and immune suppression. A better understanding is needed of mechanisms of increased liver-related mortality in people with HBV/HIV coinfection.

Interest & Impact

Downloads

0 since deposited on 20 Jul 2023
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item